74
Participants
Start Date
April 10, 2019
Primary Completion Date
March 24, 2021
Study Completion Date
March 24, 2021
BMS-986165
Oral tablet administration
Tokyo Medical University Hospital, Shinjuku-ku
National Hospital Organization Yokohama Medical Center, Yokohama
Local Institution - 0004, Matsumoto
Kurashiki Central Hospital, Kurashiki
Local Institution - 0014, Nagoya
Local Institution, Toon-Shi
Fukuoka University Hospital, Fukuoka
University of Occupational and Environmental Health, Japan, Kitakyushu
Sapporo Skin Clinic, Sapporo
Kobe University Hospital, Kobe
Local Institution, Morioka
Tokai University Hospital, Isehara
Yokohama City University Hospital, Yokohama
Kochi Medical School Hospital, Nakoku
University Hospital - Kyoto Preferctural University of Medicine, Kyoto
Kyoto University Hospital, Kyoto
Mie University Hospital, Tsu
Hamamatsu University Hospital, Hamamatsu
Jichi Medical University Hospital, Shimotsuke
Nihon University Itabashi Hospital, Itabashi-ku
The Jikei University Hospital, Minato-ku
NTT Medical Center Tokyo, Shinagawa
Japan Community Health Care Organization Tokyo Yamate Medical Center, Shinjuku
Teikyo University Hospital, tabashi City
Kumamoto University Hospital, Kumamoto
Local Institution - 0003, Osaka
Local Institution - 0012, Osaka
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY